Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

NCOA4-RET fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

KIF5B-RET fusion + RET G810C (3)

EGFR mutation + RET fusion (2)

KIF5B-RET fusion + RET G810S (2)

CCDC6-RET fusion + EGFR mutation (1)

CCDC6‐RET fusion + TERT promotor mutation (1)

GPRC6A-RET fusion + EGFR mutation (1)

KIF5B-RET fusion + EGFR exon 19 deletion (1)

KIF5B-RET fusion + MET amplification (1)

KIF5B-RET fusion + RET E732K (1)

KIF5B-RET fusion + RET L730I (1)

KIF5B-RET fusion + RET L730V (1)

KIF5B-RET fusion + RET M918T (1)

KIF5B-RET fusion + RET V804E (1)

KIF5B-RET fusion + RET V804M (1)

KIF5B-RET fusion + TP53 H193R + MYC amplification (1)

MET amplification + RET fusion (1)

PD-L1 overexpression + RET-CCDC6 fusion (1)

PD-L1 overexpression + RET-KIF5B fusion (1)

PD-L1 overexpression + RET-KIF5B fusion + TP53 mutation + AR mutation + RET rearrangement (1)

RET G810C + CCDC6-RET fusion (1)

RET amplification + TMB-H + PD-L1 expression (1)

RET positive + KRAS G12V (1)

RET positive + SMARCA4 mutation (1)

RET-MIR4299-MIR8070 fusion + RET amplification (1)

SHTN1-RET fusion + EGFR mutation (1)

SPECC1-RET fusion + EGFR mutation (1)

TLN1-RET fusion + EGFR mutation (1)

TRIM24-RET fusion + EGFR mutation (1)

TRIM33-RET fusion + EGFR mutation (1)

KIF5B-RET fusion + RET G810C (3)

EGFR mutation + RET fusion (2)

KIF5B-RET fusion + RET G810S (2)

CCDC6-RET fusion + EGFR mutation (1)

CCDC6‐RET fusion + TERT promotor mutation (1)

GPRC6A-RET fusion + EGFR mutation (1)

KIF5B-RET fusion + EGFR exon 19 deletion (1)

KIF5B-RET fusion + MET amplification (1)

KIF5B-RET fusion + RET E732K (1)

KIF5B-RET fusion + RET L730I (1)

KIF5B-RET fusion + RET L730V (1)

KIF5B-RET fusion + RET M918T (1)

KIF5B-RET fusion + RET V804E (1)

KIF5B-RET fusion + RET V804M (1)

KIF5B-RET fusion + TP53 H193R + MYC amplification (1)

MET amplification + RET fusion (1)

PD-L1 overexpression + RET-CCDC6 fusion (1)

PD-L1 overexpression + RET-KIF5B fusion (1)

PD-L1 overexpression + RET-KIF5B fusion + TP53 mutation + AR mutation + RET rearrangement (1)

RET G810C + CCDC6-RET fusion (1)

RET amplification + TMB-H + PD-L1 expression (1)

RET positive + KRAS G12V (1)

RET positive + SMARCA4 mutation (1)

RET-MIR4299-MIR8070 fusion + RET amplification (1)

SHTN1-RET fusion + EGFR mutation (1)

SPECC1-RET fusion + EGFR mutation (1)

TLN1-RET fusion + EGFR mutation (1)

TRIM24-RET fusion + EGFR mutation (1)

TRIM33-RET fusion + EGFR mutation (1)

›

NCOA4-RET fusion	Thyroid Gland Papillary Carcinoma	NCOA4-RET fusion	Thyroid Gland Papillary Carcinoma	lenvatinib Sensitive: C4 – Case Studies lenvatinib Sensitive : C4	lenvatinib Sensitive: C4 – Case Studies lenvatinib Sensitive : C4
NCOA4-RET fusion	Thyroid Gland Carcinoma	NCOA4-RET fusion	Thyroid Gland Carcinoma	pralsetinib Sensitive: C4 – Case Studies pralsetinib Sensitive : C4	pralsetinib Sensitive: C4 – Case Studies pralsetinib Sensitive : C4
NCOA4-RET fusion	Cholangiocarcinoma	NCOA4-RET fusion	Cholangiocarcinoma	pralsetinib Sensitive: C4 – Case Studies pralsetinib Sensitive : C4	pralsetinib Sensitive: C4 – Case Studies pralsetinib Sensitive : C4
NCOA4-RET fusion	Thyroid Gland Papillary Carcinoma	NCOA4-RET fusion	Thyroid Gland Papillary Carcinoma	selpercatinib Sensitive: C4 – Case Studies selpercatinib Sensitive : C4	selpercatinib Sensitive: C4 – Case Studies selpercatinib Sensitive : C4
NCOA4-RET fusion	Non Small Cell Lung Cancer	NCOA4-RET fusion	Non Small Cell Lung Cancer	RXDX-105 Sensitive: D – Preclinical RXDX-105 Sensitive : D	RXDX-105 Sensitive: D – Preclinical RXDX-105 Sensitive : D
NCOA4-RET fusion	Ovarian Cancer	NCOA4-RET fusion	Ovarian Cancer	FHND5071 Sensitive: D – Preclinical FHND5071 Sensitive : D	FHND5071 Sensitive: D – Preclinical FHND5071 Sensitive : D